BusinessCellular Biomedicine Group Announces Closing of $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a Wholly-Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc.By Nasdaq OMXApr 19, 2016, 12:30 PM UTC
BusinessQ2 Economic Outlook Forecasts 2.7% Growth In Equipment and Software Investment in 2016By Nasdaq OMXApr 11, 2016, 12:00 PM UTC
BusinessIndustry Veteran Andrew Barnicke Joins Colliers as Vice Chairman, Capital Markets, CanadaBy Nasdaq OMXApr 4, 2016, 2:00 PM UTC
BusinessEconomic and Election-Year Uncertainties Won’t Deter Active Investors in 2016By Nasdaq OMXMar 16, 2016, 11:40 AM UTC
Business2016 FOX Spring Global Investment Forum™ to Bring Together Leading Minds in Family InvestmentBy Nasdaq OMXMar 15, 2016, 2:00 PM UTC
BusinessDavid Tarquin Joins WNC to Lead Company’s New Preservation Equity Funds Product LineBy Nasdaq OMXMar 7, 2016, 5:40 PM UTC
BusinessMassRoots Closes $77,000 in Advertising Contracts Last WeekBy Nasdaq OMXFeb 22, 2016, 1:00 PM UTC
BusinessCellular Biomedicine Group Announces a $43.13 Million Strategic Investment From Dangdai International Group Co., Limited, a Wholly Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc.By Nasdaq OMXFeb 4, 2016, 2:09 PM UTC
